PARK3 genetic Parkinson's disease (PD)
Evidence-based neurology checklist on park3 genetic parkinson's disease (pd): Genetics This is caused by mutations on chromosome 2p The transmission is autosomal dominant Clinical features Treatment
Genetics
- This is caused by mutations on chromosome 2p
- The transmission is autosomal dominant
Clinical features
Treatment
References
- Gasser T, Müller-Myhsok B, Wszolek ZK, et al. A susceptibility locus for Parkinson's disease maps to chromosome 2p13. Nat Genet 1998; 18:262-265.
- DeStefano AL, Lew MF, Golbe LI, et al. PARK3 influences age at onset in Parkinson disease: a genome scan in the GenePD study. Am J Hum Genet 2002; 70:1089-1095.
- Karamohamed S, DeStefano AL, Wilk JB, et al; GenePD study. A haplotype at the PARK3 locus influences onset age for Parkinson's disease: the GenePD study. Neurology 2003; 61:1557-1561.
Related checklists
- PARK1 genetic Parkinson's disease (PD)
- PARK2 genetic Parkinson's disease (PD)
- PARK4 genetic Parkinson's disease (PD)
- PARK5 genetic Parkinson's disease (PD)
- PARK6 genetic Parkinson's disease (PD)
- PARK7 genetic Parkinson's disease (PD)
- PARK8 genetic Parkinson's disease (PD)
- PARK9 genetic Parkinson's disease (PD)
- PARK10 genetic Parkinson's disease (PD)
- PARK11 genetic Parkinson's disease (PD)
- PARK12 genetic Parkinson's disease (PD)
- PARK13 genetic Parkinson's disease (PD)
- PARK14 genetic Parkinson's disease (PD)
- PARK15 genetic Parkinson's disease (PD)
- PARK16 genetic Parkinson's disease (PD)
- PARK17 genetic Parkinson's disease (PD)
- PARK18 genetic Parkinson's disease (PD)
- PARK19 genetic Parkinson's disease (PD)
- PARK20 genetic Parkinson's disease (PD)
- PARK21 genetic Parkinson's disease (PD)
- PARK22 genetic Parkinson's disease (PD)
- PARK23 genetic Parkinson's disease (PD)
- Glucocerebrosidase (GBA) parkinsonism
- Perry syndrome
- Parkinsonism with intellectual disability